MicroPort Scientific Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

MicroPort Scientific wird ein jährliches Gewinn- und Umsatzwachstum von 72.7% bzw. 15.3% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 72% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich -19.8% betragen.

Wichtige Informationen

72.7%

Wachstumsrate der Gewinne

72.0%

EPS-Wachstumsrate

Medical Equipment Gewinnwachstum	39.9%
Wachstumsrate der Einnahmen	15.3%
Zukünftige Eigenkapitalrendite	-19.8%
Analystenabdeckung	Good
Zuletzt aktualisiert	08 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Gewinn- und Umsatzwachstumsprognosen

SHSC:853 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	1,577	-17	165	56	5
12/31/2025	1,297	-158	108	-213	8
12/31/2024	1,111	-211	-173	-136	6
6/30/2024	1,027	-412	-269	-102	N/A
3/31/2024	989	-445	-350	-167	N/A
12/31/2023	951	-478	-431	-232	N/A
9/30/2023	935	-439	-513	-288	N/A
6/30/2023	918	-401	-595	-345	N/A
3/31/2023	880	-419	-598	-344	N/A
12/31/2022	841	-437	-601	-343	N/A
9/30/2022	820	-410	-603	-328	N/A
6/30/2022	799	-384	-605	-313	N/A
3/31/2022	789	-330	-555	-285	N/A
12/31/2021	779	-276	-505	-258	N/A
9/30/2021	753	-246	-382	-198	N/A
6/30/2021	726	-216	-260	-138	N/A
3/31/2021	688	-204	-202	-81	N/A
12/31/2020	649	-191	-144	-23	N/A
9/30/2020	678	-138	-119	0	N/A
6/30/2020	708	-85	-93	24	N/A
3/31/2020	751	-19	-91	25	N/A
12/31/2019	793	46	-89	26	N/A
9/30/2019	773	56	-79	35	N/A
6/30/2019	752	66	-70	44	N/A
3/31/2019	711	45	-38	64	N/A
12/31/2018	669	24	-6	84	N/A
9/30/2018	603	23	4	95	N/A
6/30/2018	537	21	13	106	N/A
3/31/2018	490	20	N/A	102	N/A
12/31/2017	444	19	N/A	97	N/A
9/30/2017	426	25	N/A	93	N/A
6/30/2017	409	31	N/A	89	N/A
3/31/2017	399	22	N/A	86	N/A
12/31/2016	390	14	N/A	83	N/A
9/30/2016	387	5	N/A	68	N/A
6/30/2016	383	-4	N/A	54	N/A
3/31/2016	379	-8	N/A	42	N/A
12/31/2015	376	-12	N/A	31	N/A
9/30/2015	369	-32	N/A	29	N/A
6/30/2015	363	-52	N/A	28	N/A
3/31/2015	359	-56	N/A	23	N/A
12/31/2014	355	-59	N/A	18	N/A
9/30/2014	312	-30	N/A	24	N/A
6/30/2014	268	-1	N/A	31	N/A
3/31/2014	210	12	N/A	44	N/A
12/31/2013	152	24	N/A	58	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: 853 wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Ertrag vs. Markt: 853 wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Hohe Wachstumserträge: 853 wird in den nächsten 3 Jahren voraussichtlich unrentabel bleiben.

Einnahmen vs. Markt: 853Die Einnahmen des Unternehmens (15.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Hong Kong (7.8% pro Jahr).

Hohe Wachstumseinnahmen: 853Die Einnahmen des Unternehmens (15.3% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: 853 wird voraussichtlich in 3 Jahren unrentabel sein.

MicroPort Scientific Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Microport Scientific Corporation Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023

No longer forecast to breakeven

MicroPort Scientific Corporation Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2022

MicroPort Scientific Corporation Provides Consolidated Earnings Guidance for the Full Year Ended December 31, 2021

Recent updates

New minor risk - Share price stability

First half 2024 earnings released: US$0.053 loss per share (vs US$0.089 loss in 1H 2023)

MicroPort Scientific Corporation to Report First Half, 2024 Results on Aug 30, 2024

MicroPort Scientific Corporation Announces Firesorb Bioresorbable Coronary Scaffold System Obtained Approval for Marketing from the NMPA

MicroPort Scientific Corporation Announces Firesorb Bioresorbable Coronary Scaffold System Obtained Approval for Marketing from the NMPA

Now 44% undervalued after recent price drop

Now 23% undervalued after recent price drop

Microport Scientific Corporation Announces Retirement of Non-Executive Directors

Now 22% undervalued after recent price drop

MicroPort Scientific Corporation, Annual General Meeting, May 22, 2024

Full year 2023 earnings released: US$0.26 loss per share (vs US$0.24 loss in FY 2022)

MicroPort Scientific Corporation to Report Fiscal Year 2023 Results on Mar 28, 2024

New minor risk - Share price stability

Now 40% undervalued after recent price drop

MicroPort Scientific Corporation Announces Appointment of Peng Bo as Non-Executive Director and Member of the Strategic Committee

First half 2023 earnings released: US$0.089 loss per share (vs US$0.11 loss in 1H 2022)

MicroPort Scientific Corporation to Report First Half, 2023 Results on Aug 30, 2023

Microport Scientific Corporation Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023

Now 22% undervalued after recent price drop

MicroPort Scientific Corporation Announces Board Changes

Independent Non-Executive Director recently sold HK$2.1m worth of stock

MicroPort Scientific Corporation, Annual General Meeting, Jun 19, 2023

Independent Non-Executive Director recently sold HK$5.3m worth of stock

No longer forecast to breakeven

Full year 2022 earnings released: US$0.24 loss per share (vs US$0.15 loss in FY 2021)

Microport Scientific Corporation Announces That Hiroshi Shirafuji Has Accepted the Invitation to Act as the Honorary Chairman

Less than half of directors are independent

First half 2022 earnings released: US$0.11 loss per share (vs US$0.05 loss in 1H 2021)

MicroPort Scientific Corporation Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2022

Full year 2021 earnings released: US$0.15 loss per share (vs US$0.11 loss in FY 2020)

Less than half of directors are independent

Full year 2021 earnings released: US$0.15 loss per share (vs US$0.11 loss in FY 2020)

MicroPort Scientific Corporation, Annual General Meeting, Jun 23, 2022

Less than half of directors are independent

MicroPort Scientific Corporation Provides Consolidated Earnings Guidance for the Full Year Ended December 31, 2021

Now 22% undervalued after recent price drop

First half 2021 earnings released: US$0.05 loss per share (vs US$0.039 loss in 1H 2020)

Upcoming dividend of HK$0.043 per share

MicroPort Scientific Corporation Proposes Final Dividend for the Year Ended 31 December 2020

Full year 2020 earnings released: US$0.11 loss per share (vs US$0.029 profit in FY 2019)

Full year 2020 earnings released: US$0.11 loss per share (vs US$0.029 profit in FY 2019)

New 90-day high: HK$55.10

New 90-day high: HK$48.75

New 90-day high: HK$41.65

New 90-day high: HK$37.65

New 90-day low: HK$28.80

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken